Class information for:
Level 1: DONOR LYMPHOCYTE INFUSION//REDUCED INTENSITY CONDITIONING//CHIMERISM

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1858 2454 36.4 86%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
51 3       HEMATOLOGY//BONE MARROW TRANSPLANTATION//BLOOD 91443
128 2             BONE MARROW TRANSPLANTATION//HEMATOLOGY//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 23958
1858 1                   DONOR LYMPHOCYTE INFUSION//REDUCED INTENSITY CONDITIONING//CHIMERISM 2454

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 DONOR LYMPHOCYTE INFUSION authKW 622410 5% 42% 119
2 REDUCED INTENSITY CONDITIONING authKW 603902 6% 33% 146
3 CHIMERISM authKW 534717 7% 25% 172
4 BONE MARROW TRANSPLANTATION journal 429378 22% 6% 550
5 GRAFT VERSUS TUMOR EFFECT authKW 379269 2% 61% 50
6 DONOR LEUKOCYTE INFUSION authKW 350408 2% 72% 39
7 NONMYELOABLATIVE authKW 331333 3% 42% 63
8 REDUCED INTENSITY authKW 237106 2% 44% 43
9 ALLOGENEIC STEM CELL TRANSPLANTATION authKW 236505 6% 14% 140
10 GRAFT VERSUS LEUKEMIA authKW 209195 2% 32% 53

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Hematology 134450 71% 1% 1734
2 Transplantation 80971 38% 1% 926
3 Immunology 16205 39% 0% 964
4 Oncology 15725 42% 0% 1025
5 Medicine, Research & Experimental 371 6% 0% 141
6 Cell & Tissue Engineering 318 1% 0% 28
7 Medicine, General & Internal 63 4% 0% 102
8 Surgery 35 4% 0% 110
9 Pathology 34 2% 0% 44
10 Medical Laboratory Technology 31 1% 0% 21

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BONE MARROW TRANSPLANTAT CANC IMMUNOTHER 92509 1% 28% 27
2 DANNY CUNNIFF LEUKEMIA 76201 0% 88% 7
3 UNITE TRANSPLANTAT THER IE CELLULAIRE 45137 1% 26% 14
4 CANC IMMUNOTHER Y IMMUNOBIOL 42996 0% 31% 11
5 CTCG 39811 0% 80% 4
6 UTTC 39803 0% 40% 8
7 BONE MARROW TRANSPLANT CANC IMMUNOTHER Y 37906 0% 38% 8
8 EBMT DATA 37324 0% 100% 3
9 HEMATOL 36618 16% 1% 382
10 UNITE TRANSPLANTAT MEDULLAIRE 30329 0% 24% 10

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BONE MARROW TRANSPLANTATION 429378 22% 6% 550
2 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 209163 9% 7% 226
3 BRITISH JOURNAL OF HAEMATOLOGY 11871 5% 1% 114
4 BLOOD 11427 7% 1% 179
5 LEUKEMIA 7305 3% 1% 67
6 BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY 7143 1% 3% 22
7 INTERNATIONAL JOURNAL OF HEMATOLOGY 6917 2% 1% 46
8 ANNALS OF HEMATOLOGY 6498 2% 1% 44
9 EXPERIMENTAL HEMATOLOGY 5596 2% 1% 51
10 HAEMATOLOGICA 5153 2% 1% 39

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 DONOR LYMPHOCYTE INFUSION 622410 5% 42% 119 Search DONOR+LYMPHOCYTE+INFUSION Search DONOR+LYMPHOCYTE+INFUSION
2 REDUCED INTENSITY CONDITIONING 603902 6% 33% 146 Search REDUCED+INTENSITY+CONDITIONING Search REDUCED+INTENSITY+CONDITIONING
3 CHIMERISM 534717 7% 25% 172 Search CHIMERISM Search CHIMERISM
4 GRAFT VERSUS TUMOR EFFECT 379269 2% 61% 50 Search GRAFT+VERSUS+TUMOR+EFFECT Search GRAFT+VERSUS+TUMOR+EFFECT
5 DONOR LEUKOCYTE INFUSION 350408 2% 72% 39 Search DONOR+LEUKOCYTE+INFUSION Search DONOR+LEUKOCYTE+INFUSION
6 NONMYELOABLATIVE 331333 3% 42% 63 Search NONMYELOABLATIVE Search NONMYELOABLATIVE
7 REDUCED INTENSITY 237106 2% 44% 43 Search REDUCED+INTENSITY Search REDUCED+INTENSITY
8 ALLOGENEIC STEM CELL TRANSPLANTATION 236505 6% 14% 140 Search ALLOGENEIC+STEM+CELL+TRANSPLANTATION Search ALLOGENEIC+STEM+CELL+TRANSPLANTATION
9 GRAFT VERSUS LEUKEMIA 209195 2% 32% 53 Search GRAFT+VERSUS+LEUKEMIA Search GRAFT+VERSUS+LEUKEMIA
10 DLI 196593 1% 44% 36 Search DLI Search DLI

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 RESHEF, R , PORTER, DL , (2015) REDUCED-INTENSITY CONDITIONED ALLOGENEIC SCT IN ADULTS WITH AML.BONE MARROW TRANSPLANTATION. VOL. 50. ISSUE 6. P. 759 -769 80 56% 9
2 BADER, P , NIETHAMMER, D , WILLASCH, A , KREYENBERG, H , KLINGEBIEL, T , (2005) HOW AND WHEN SHOULD WE MONITOR CHIMERISM AFTER ALLOGENEIC STEM CELL TRANSPLANTATION?.BONE MARROW TRANSPLANTATION. VOL. 35. ISSUE 2. P. 107-119 78 73% 79
3 FADILAH, SAW , AQILAH, MP , (2012) PROMISING ROLE OF REDUCED-TOXICITY HEMATOPOIETIC STEM CELL TRANSPLANTATION (PART-I).STEM CELL REVIEWS AND REPORTS. VOL. 8. ISSUE 4. P. 1254-1264 79 60% 5
4 CHANG, X , ZANG, X , XIA, CQ , (2016) NEW STRATEGIES OF DLI IN THE MANAGEMENT OF RELAPSE OF HEMATOLOGICAL MALIGNANCIES AFTER ALLOGENEIC HEMATOPOIETIC SCT.BONE MARROW TRANSPLANTATION. VOL. 51. ISSUE 3. P. 324 -332 59 60% 3
5 BARON, F , SANDMAIER, BM , (2006) CHIMERISM AND OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOLLOWING NONMYELOABLATIVE CONDITIONING.LEUKEMIA. VOL. 20. ISSUE 10. P. 1690-1700 59 77% 91
6 LOREN, AW , PORTER, DL , (2006) DONOR LEUKOCYTE INFUSIONS AFTER UNRELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION.CURRENT OPINION IN ONCOLOGY. VOL. 18. ISSUE 2. P. 107-114 53 91% 22
7 LIU, HT , LIU, DH , HUANG, XJ , ARTZ, A , BISHOP, MR , (2013) TREATMENTS OF DISEASE RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOCUSING ON DONOR LYMPHOCYTE INFUSION.CHINESE MEDICAL JOURNAL. VOL. 126. ISSUE 22. P. 4380-4388 53 74% 1
8 SHAW, BE , RUSSELL, NH , (2008) TREATMENT OPTIONS FOR THE MANAGEMENT OF ACUTE LEUKAEMIA RELAPSING FOLLOWING AN ALLOGENEIC TRANSPLANT.BONE MARROW TRANSPLANTATION. VOL. 41. ISSUE 5. P. 495 -503 56 75% 20
9 KASSIM, AA , CHINRATANALAB, W , FERRARA, JLM , MINEISHI, S , (2005) REDUCED-INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE LEUKEMIAS: 'WHAT IS THE BEST RECIPE?'.BONE MARROW TRANSPLANTATION. VOL. 36. ISSUE 7. P. 565-574 66 70% 12
10 CHRISTOPEIT, M , KUSS, O , FINKE, J , BACHER, U , BEELEN, DW , BORNHAUSER, M , SCHWERDTFEGER, R , BETHGE, WA , BASARA, N , GRAMATZKI, M , ET AL (2013) SECOND ALLOGRAFT FOR HEMATOLOGIC RELAPSE OF ACUTE LEUKEMIA AFTER FIRST ALLOGENEIC STEM-CELL TRANSPLANTATION FROM RELATED AND UNRELATED DONORS: THE ROLE OF DONOR CHANGE.JOURNAL OF CLINICAL ONCOLOGY. VOL. 31. ISSUE 26. P. 3259-+ 37 88% 24

Classes with closest relation at Level 1


Rank Class id link
1 4895 HAPLOIDENTICAL//UNRELATED DONOR//HAPLOIDENTICAL TRANSPLANTATION
2 15463 STEM CELL TRANSPLANTAT PROGRAMME//BONE MARROW TRANSPLANTATION//CD6 ANTIBODY
3 15248 MINOR HISTOCOMPATIBILITY ANTIGENS//HA 1//HY ANTIGENS
4 23373 IMMUNOL BIOTHER Y PROGRAM//INTERLEUKIN 2//MHC NONRESTRICTED CYTOTOXICITY
5 13850 BUSULFAN//TREOSULFAN//BU
6 25981 DONOR CELL LEUKEMIA//DONOR CELL DERIVED LEUKEMIA//DONOR CELL DERIVED SECONDARY LEUKAEMIA
7 880 GRAFT VERSUS HOST DISEASE//CHRONIC GRAFT VERSUS HOST DISEASE//GVHD
8 15817 PRAME//LEUKEMIA ASSOCIATED ANTIGENS//PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA
9 19183 INT TRANSPLANTAT THALASSEMIA SICKLE CELL AN//MEDITERRANEAN HEMATOL//TR IANTO MIDOLLO OSSEO MURAGLIA
10 8809 CML//CHRONIC MYELOGENOUS LEUKEMIA//AUTOGRAFTING

Go to start page